Currently set to Index
Currently set to Follow

Watch 3-min pitch video

Surge-on Medical - FINAL CALL

Funding Target
€500,000
Equity offered
12.74%
Funded 117.6% €588,000

Venture Category: MedTech
Business Phase: Sales Expansion
Professional Investors: 1 VC, 2 Family Offices

Other project open for investment

Lipozyt

Diagnostic Tests for the Personalized Treatment of Type 2 Diabetes

This investment opportunity is brokered by aescuvest GmbH on our independent platform aescuvest.de

Legal notice according to the German Capital Investments Act (VermAnlG): This investment carries considerable risks and may lead to an entire loss of the assets invested. The expected yield is not guaranteed and may be lower.

I agree

Investment opportunities

Get notified when new campaigns are launched

Starting in June: #CrowdBeatsCorona

PharmGenomics

Coronascreen: Contactless, online-based Laboratory Diagnostics

This investment opportunity is brokered by aescuvest GmbH on our independent platform aescuvest.de

Legal notice according to the German Capital Investments Act (VermAnlG): This investment carries considerable risks and may lead to an entire loss of the assets invested. The expected yield is not guaranteed and may be lower.

I agree

Proteona Antibody Protection

SARS-CoV-2 Broadly Neutralizing Antibody Therapy

This investment opportunity is brokered by aescuvest GmbH on our independent platform aescuvest.de

Legal notice according to the German Capital Investments Act (VermAnlG): This investment carries considerable risks and may lead to an entire loss of the assets invested. The expected yield is not guaranteed and may be lower.

I agree

ImmunoLogik

ImmunoLogik’s candidate against coronavirus

This investment opportunity is brokered by aescuvest GmbH on our independent platform aescuvest.de

Legal notice according to the German Capital Investments Act (VermAnlG): This investment carries considerable risks and may lead to an entire loss of the assets invested. The expected yield is not guaranteed and may be lower.

I agree

Upcoming funding campaigns

Emperra

Helping to make life with Diabetes mellitus easier

This investment opportunity is brokered by aescuvest GmbH on our independent platform aescuvest.de

Legal notice according to the German Capital Investments Act (VermAnlG): This investment carries considerable risks and may lead to an entire loss of the assets invested. The expected yield is not guaranteed and may be lower.

I agree

Alma Bio Therapeutics

Employs the Language of the Immune System to Improve Patients’ Health

This investment opportunity is brokered by aescuvest GmbH on our independent platform aescuvest.de

Legal notice according to the German Capital Investments Act (VermAnlG): This investment carries considerable risks and may lead to an entire loss of the assets invested. The expected yield is not guaranteed and may be lower.

I agree

Mowoot

Solving intestinal transit disorders purely physical, non-drug, non-invasive.

This investment opportunity is brokered by aescuvest GmbH on our independent platform aescuvest.de

Legal notice according to the German Capital Investments Act (VermAnlG): This investment carries considerable risks and may lead to an entire loss of the assets invested. The expected yield is not guaranteed and may be lower.

I agree

NanoVelos

Getting drugs to their targets with significant side effects reduction

Invest in Health

Successfully funded on our sister platform aescuvest.de

Get notified

of new campaigns and news.
We do not sell or share your data to third parties. View our Privacy notice